Salarius Pharmaceuticals Inc. Raises $3.8 Million Through Issuance of 5.5 Million Shares Under Equity Line of Credit
Salarius Pharmaceuticals Inc. raised approximately $3.8 million by issuing 5.5 million shares of common stock under an equity line of credit. The transactions took place between July 10 and July 30, 2025, as part of a Securities Purchase Agreement with C/M Capital Master Fund, LP. The original content was published via EDGAR on July 31, 2025.
Salarius Pharmaceuticals Inc. issued and sold a total of 5.5 million shares of its common stock for gross proceeds of approximately $3.8 million. These transactions occurred from July 10, 2025, through July 30, 2025, under a Securities Purchase Agreement with C/M Capital Master Fund, LP. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Salarius Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001615219-25-000080), on July 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
